445 filings
Page 4 of 23
EFFECT
wfbb6h syx
4 Apr 23
Notice of effectiveness
12:15am
CORRESP
tmf 206jnsc
30 Mar 23
Correspondence with SEC
12:00am
UPLOAD
6n1eev
28 Mar 23
Letter from SEC
12:00am
F-3
g2vr1i3mx5m5xv1l7f9a
24 Mar 23
Shelf registration (foreign)
6:39am
6-K
lsdc2o
22 Mar 23
Current report (foreign)
7:59pm
6-K
futsr89mw
15 Mar 23
Current report (foreign)
8:34pm
6-K
0jx5ys
7 Mar 23
Current report (foreign)
7:37pm
6-K
43fy6
27 Feb 23
Current report (foreign)
8:19pm
6-K
ftbb vuzpqkq8ye
27 Feb 23
Provided to the Asx Under Listing Rule 4.2A
5:49pm
6-K
c1vwav
21 Feb 23
Remestemcel-l Clinical and Potency Studies Presented at Premier Meeting of Transplantation Research and Therapy
5:56pm
6-K
pnx8fam8ligkn7bt
13 Feb 23
Current report (foreign)
8:59pm
6-K
2uql rrz1gsm8atne0n
1 Feb 23
Appendix 4C Quarterly Activity Report
5:13pm
SC 13G/A
7crgc sjd3yb
20 Jan 23
MESOBLAST / M&G INVESTMENT MANAGEMENT ownership change
8:58am
6-K
ulann06tghjvbqdhaib
17 Jan 23
Current report (foreign)
7:39pm
EFFECT
nypmvnr gd
3 Jan 23
Notice of effectiveness
12:15am
424B3
xkuz0
30 Dec 22
Prospectus supplement
3:32pm
6-K
aw34hh9vpfdn3
28 Dec 22
Current report (foreign)
8:47pm
UPLOAD
bg6xc0vx3m m4gv
28 Dec 22
Letter from SEC
12:00am
CORRESP
g42u22a
28 Dec 22
Correspondence with SEC
12:00am
424B3
1fn gc2tdax
27 Dec 22
Prospectus supplement
6:15am